[1] ZHONG XL, WANG XY, LIN AH, et al.Investigation and intervention study on the safety of intravenous infusion in children[J]. Clinical Medication Journal(临床药物治疗杂志), 2017,15(10): 21-23. [2] LI YD, ZHANG L.Cause analysis and nursing treatment of children's intravenous infusion leakage[J]. Laboratory Medicine and Clinic(检验医学与临床), 2019, 16(9): 134-135. [3] LIU EM, LU Q.Focus on safe and rational use of drugs for children[J]. Chinese Journal of Pediatrics(中华儿科杂志), 2020, 58(1): 6-8. [4] China National Formulary Editorial Committee. "China National Formulary" (Children's Edition) [中国国家处方集(儿童版)][M]. Beijing: People's Military Medical Press, 2013. [5] National Center for ADR Monitoring, China, Technical specifications and evaluation standards for common serious adverse drug reactions(常见严重药品不良反应技术规范及评价标准)[S]. China, 2010. [6] National Medical Products Administration. Announcement of the National Medical Products Administration on the release of the Annual Report for National ADR monitoring(2017)[EB/OL]. (2018-04-13) [2021-01-11]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20180413171401472.html. [7] YANG LY, LIU XS, XIAO W, et al.Adverse reactions and countermeasures of drugs for children in China[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2016, 41(14): 2743-2747. [8] GUO PF, ZHAO P.Analysis of 1019 adverse drug reaction reports in children through intravenous infusion in outpatient department[J]. Journal of Pediatric Pharmacy(儿科药学杂志), 2012, 18(1): 31-33. [9] LIU C, LIU SY, ZHANG T, et al.Construction of informationalized adverse drug reactions reporting system[J]. Chinese Journal of Pharmac-ovigilance(中国药物警戒), 2020, 17(8): 471-473. [10] ZHANG WH, CHEN H, WANG F, et al.Analysis of 303 cases of adverse drug reactions of intravenous transfusion in Wuhan children's hospital[J]. Herald of Medicine(医药导报), 2014, 33(48): 530-533. [11] JIANG J, LIN Z, DU T.Retrospective analysis of adverse drug reactions in pediatrics of a military hospital[J]. Journal of Pediatric Pharmacy(儿科药学杂志), 2019, 25(5): 42-47. [12] XU HZ.Clinical analysis of five cases of neonatal severe allergic reaction to antibiotics[J]. Pediatric Emergency Medicine(中国小儿急救医学, 1999, 6(2): 67-68. [13] LIU Y.Clinical observation and emergency treatment of two cases of neonatal penicillin allergy[J]. Practical Pharmacy and Clinical Remedies(实用药物与临床), 2015, 18(11): 1373-1375. [14] ZHOU GY, CAO F, SU H.Analysis of adverse drug reactions in 2527 children[J]. Journal of Pharmaceutical Research(药学研究), 2018, 37(5): 307-310. [15] WANG RQ, HUO YF, XIE YJ, et al.Retrospective analysis of 530 cases of new/severe pediatric ADR in Shandong province during 2016-2017[J]. China Pharmacy(中国药房), 2019, 30(1): 115-119. [16] FANG SX, YANG Y.Analysis of clinical medications in children with acute bronchopneumonia[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(12): 746-750. [17] NI BB, QIN M, SUN C, et al.Research advances of parenteral nutrition-associated cholestasis in neonates[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2020, 22(8): 471-476. [18] LU QG, HE SX, OU MF.Analysis on adverse reactions and risk factors of intravenous infusion in children[J]. China Pharmaceuticals(中国药业), 2018, 27(13): 95-97. [19] WANG L.The necessity and feasibility to establish the group of pediatric clinical pharmacology[J]. Journal of Pediatric Pharmacy(儿科药学杂志), 2009, 15(4): 1-4. |